Eli Ipp, M.D.
In the past three years, Dr. Ipp has received grant/research support from Pfizer, Inc., R.W. Johnson, and Novo-Nordisk. He has served as a consultant for Novo-Nordisk, SmithKline Beecham Pharmaceutical and Hoechst Marion Roussel. Dr Ipp has also served on the Speakers' Bureau for Novo-Nordisk.
Release Date: 05/12/1999
Upon completion of this Cyberounds®, you should be able to:
List the criteria for screening and diagnosis of diabetes in pregnancy
Discuss the new criteria for diagnosis of diabetes in the non-pregnant state
Describe the risks for developing permanent Type 2 diabetes in a woman who has had gestational diabetes.
